| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1865 | Ds42450411 | Novel potent orally active hepcidin production inhibitor |
|
| DCC1866 | Ds79932728 | Novel Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease |
|
| DCC1867 | Dsba Inhibitor F1 | Pathogen motility inhibitor of EcDsbA |
|
| DCC1868 | Dshs00884 | Non-toxic human papillomavirus E6 inhibitor |
|
| DCC1869 | Dsm-338 | Novel Plasmodium falciparum Dihydroorotate Dehydrogenase (PfDHODH) Inhibitor (Pfalcip cells: 0.0018 μM) |
|
| DCC1870 | Dsm502 Featured | Novel potent inhibitor of dihydroorotate dehydrogenase (DHODH) |
|
| DCC1871 | Dsm705 | Novel potent Dihydroorotate Dehydrogenase (DHODH) inhibitor |
|
| DCC1872 | Dsr-98776 | Novel selective mGlu5 receptor negative allosteric modulator (NAM) with potent antidepressant and antimanic activity |
|
| DCC1873 | Ds-sg-44 | Agonist of S1P receptors |
|
| DCC1874 | Dt-061 | Novel potent and orally active activator of PP2A |
|
| DCC1875 | Dt2216nc | Negative control for DT2216 |
|
| DCC1876 | Dtagv-1 | Potent and selective degrader of mutant FKBP12F36V fusion proteins |
|
| DCC1877 | Du-34569 Maleate | Antiviral agent against influenza A, parainfluenza Sendai, coxsackie A21, and rhinovirus |
|
| DCC1878 | Duocarmycin A | Irreversible DNA minor groove binding alkylating agent, disrupting the nucleic acid architecture and leading to tumor cell death |
|
| DCC1879 | Dutomycin | Anthracycline antibiotic from Streptomyces |
|
| DCC1880 | Dv-7028 | Selective 5-HT2A receptor antagonist |
|
| DCC1881 | Dv-7028 Hydrochloride | Potent and selective 5-HT 2A receptor antagonist |
|
| DCC1882 | Dw10075 | Novel potent and highly selective inhibitor of VEGFR, exhibiting antitumor activities both in vitro and in vivo. |
|
| DCC1883 | Dw-1350 | Novel and potent leukotriene B(4) receptor antagonist |
|
| DCC1884 | Dwn-723-23 | Novel Hsp70 agonist, showing no cellular toxicity and induced cellular stress response pathways |
|
| DCC1885 | Dx2-hsp70 Inhibitor-1 | Novel allosteric inhibitor of the tumor-promoting interaction between the oncogenic factor AIMP2-DX2 and HSP70 |
|
| DCC1886 | Dx-52-1 | Antitumor antibiotic |
|
| DCC1887 | Dy3002 | Novel Selective and Potent EGFR Inhibitor, Overcoming T790M-Mediated Resistance in Non-Small Cell Lung Cancer |
|
| DCC1888 | Dy428174 | Novel potent Inhibitor of PI3Kalpha |
|
| DCC1889 | E09241 | Novel OPG/RANKL upregulator, increasing OPG expression without affecting RANKL expression, promoting osteoblast differentiation while inhibiting osteoclast differentiation, regulating OPG expression through canonical Wnt/β-catenin signaling |
|
| DCC1890 | e2012-bpyne | γ-Secretase modulator (GSM) photoaffinity probe, revealing distinct allosteric binding sites on presenilin |
|
| DCC1891 | E235-1756 | Potent Activator of P53-Independent Cellular Senescence |
|
| DCC1892 | E3-ligase Degrader 10 | Novel XIAP BIR2 domain-binding degrader of E3 ubiquitin ligases |
|
| DCC1893 | E-5842 Citrate | Sigma1 receptor ligand and potential atypical antipsychotic |
|
| DCC1894 | Ea-b3a | Novel degrader of GST-α and GST-α-EGFP fusion proteins as well as endogenous GST-π in cells and lysates |
|
